TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells

International Journal of Biochemistry and Cell Biology

Volumn 53, Issue , 2014, Pages 195-201

  Sun, Heng ^a   Li, Xuebing ^a   Fan, Li ^a   Wu, Guohao ^c   Li, Min ^d   Fang, Jing ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b BEIJING HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cell proliferation; Colon cancer; TRAF6; Tumorigenesis

Indexed keywords

ETOPOSIDE; FLUOROURACIL; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; SIGNAL PEPTIDE; TAX1BP1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; APOPTOSIS ASSAY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TISSUE MICROARRAY; TRANSIENT TRANSFECTION; ADAPTIVE IMMUNITY; APOPTOSIS; BIOSYNTHESIS; COLON TUMOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOLECULARLY TARGETED THERAPY; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNITY, INNATE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84902079998     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.04.010     Document Type: Article

References (37)

1. C. Albanese, J. Johnson, G. Watanabe, N. Eklund, D. Vu, and A. Arnold et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions J Biol Chem 270 1995 23589 23597
2. L. Bakiri, D. Lallemand, E. Bossy-Wetzel, and M. Yaniv Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression EMBO J 19 2000 2056 2068
3. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, and J. Donovan et al. The landscape of somatic copynumber alteration across human cancers Nature 463 2010 899 905
4. J.R. Bradley, and J.S. Pober Tumor necrosis factor receptor-associated factors (TRAFs) Oncogene 20 2001 6482 6491
5. Z.J. Chen Ubiquitination in signaling to and activation of IKK Immunol Rev 246 2012 95 106
6. Y. Choi Role of TRAF6 in the immune system Adv Exp Med Biol 560 2005 77 82
7. H. Clevers At the crossroads of inflammation and cancer Cell 118 2004 671 674
8. B.G. Darnay, A. Besse, A.T. Poblenz, B. Lamothe, and J.J. Jacoby TRAFs in RANK signaling Adv Exp Med Biol 597 2007 152 159
9. T. Elmetwali, L.S. Young, and D.H. Palmer CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals J Immunol 184 2010 1111 1120
10. J. Fang, C. Xia, Z. Cao, J.Z. Zheng, E. Reed, and B. Jiang Apigenin inhibits VEGF and HIF-1 expression via PI3 K/AKT/p70S6K1 and HDM2/p53 pathways FASEB J 19 2005 342 353
11. J. Fang, Q. Zhou, X.L. Shi, and B.H. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis 28 2007 713 723
12. B.B. Fu, J. Xue, Z.D. Li, X. Shi, B.H. Jiang, and J. Fang Chrysin inhibits expression of HIF-1α through reducing HIF-1α stability and inhibiting its protein synthesis Mol Cancer Ther 6 2007 220 226
13. M. Hinz, D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, and M. Strauss NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 19 1999 2690 2698
14. Y. Hirata, T. Ohmae, W. Shibata, S. Maeda, K. Ogura, and H. Yoshida et al. MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells J Immunol 176 2006 3796 3803
15. B.S. Hostager Roles of TRAF6 in CD40 signaling Immunol Res 39 2007 105 114
16. J.F. Linares, A. Duran, T. Yajima, M. Pasparakis, J. Moscat, and M.T. Diaz-Meco K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells Mol Cell 51 2013 283 296
17. X.B. Li, S. Jiao, H. Sun, J. Xue, W.T. Zhao, and L. Fan et al. The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells Cancer Lett 309 2011 137 144
18. T. Ma, N. Wang, Z. Su, L. Chen, N. Zhu, and C. Ma et al. Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6 Mol Cell Biochem 352 2011 77 85
19. Y. Ma, L. Aymeric, C. Locher, S.R. Mattarollo, N.F. Delahaye, and P. Pereira et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy J Exp Med 208 2011 491 503
20. Q. Meng, M. Zheng, H. Liu, C. Song, W. Zhang, and J. Yan et al. TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell Mol Cell Biochem 371 2012 177 186
21. Z. Peng, Y. Shuangzhu, J. Yongjie, Z. Xinjun, and L. Ying TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells Mol Cell Biochem 377 2013 87 96
22. R. Rajandram, N.C. Bennett, C. Morais, D.W. Johnson, and G.C. Gobe Renal cell carcinoma: resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins Med Hypotheses 78 2012 330 336
23. H.A. Robert, W.G. Richard, and B.T. Craig Tumor necrosis factor receptor-associated factors (TRAFs), a family of adapter proteins that regulates life and death Genes Dev 12 1998 2821 2830
24. A. Schirbel, S. Kessler, F. Rieder, G. West, N. Rebert, and K. Asosingh et al. Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis Gastroenterology 144 2013 613 623
25. B. Skaug, X. Jiang, and Z.J. Chen The role of ubiquitin in NF-κB regulatory pathways Annu Rev Biochem 78 2009 769 796
26. D.T. Starczynowski, F. Kuchenbauer, B. Argiropoulos, S. Sung, R. Morin, and A. Muranyi et al. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype Nat Med 16 2010 49 58
27. D.T. Starczynowski, W.W. Lockwood, S. Deléhouzée, R. Chari, J. Wegrzyn, and M. Fuller et al. TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer J Clin Invest 121 2011 4095 4105
28. K. Starska, E. Forma, I. Lewy-Trenda, O. Stasikowska, M. Bryś, and W.M. Krajewska et al. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma Folia Histochem Cytobiol 47 2009 401 410
29. H. Sun, X.B. Li, Y. Meng, L. Fan, M. Li, and J. Fang TRAF6 upregulates expression of HIF-1α and promotes tumor angiogenesis Cancer Res 73 2013 4950 4959
30. S. Vallabhapurapu, and M. Karin Regulation and function of NF-κB transcription factors in the immune system Annu Rev Immunol 27 2009 693 733
31. J. Wei, Y. Yuan, C. Jin, H. Chen, L. Leng, and F. He et al. The ubiquitin ligase TRAF6 negatively regulates the JAK-STAT signaling pathway by binding to STAT3 and mediating its ubiquitination PLoS One 7 2012 e49567
32. J. Xue, X. Li, S. Jiao, Y. Wei, G. Wu, and J. Fang Prolyl hydroxylase-3 is downregulated in colorectal cancer cells and inhibits IKKβ, independent of hydroxylase activity Gastroenterology 138 2010 606 615
33. M. Yamashita, K. Fatyol, C. Jin, X. Wang, Z. Liu, and Y.E. Zhang TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta Mol Cell 31 2008 918 924
34. W.L. Yang, J. Wang, C.H. Chan, S.W. Lee, A.D. Campos, and B. Lamothe et al. The E3 ligase TRAF6 regulates AKT ubiquitination and activation Science 325 2009 1134 1138
35. F. Yao, Q. Han, C. Zhong, and H. Zhao TRAF6 promoted the tumorigenicity of esophageal squamous cell carcinoma Tumour Biol 34 2013 3201 3207
36. J.M. Zapata, M. Krajewska, S. Krajewski, S. Krajewski, S. Kitada, and K. Welsh et al. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies J Immunol 165 2000 5084 5096
37. L. Zhong, F. Cao, and Q. You Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell Tumour Biol 34 2013 231 239